Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy

Resource Information

The work Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy represents a distinct intellectual or artistic creation found in University of Missouri-St. Louis Libraries. This resource is a combination of several types including: Work, Language Material, Books, http://bibfra.me/vocab/marc/conference-publication.

Label

Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy

Creator

• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2005

Contributor

• International Agency for Research on Cancer
• World Health Organization

Subject

• Cancer -- Risk factors
• Cancer -- Risk factors
• Carcinogens
• Catechol estrogens -- Carcinogenicity
• Catechol estrogens -- Side effects
• Chemical carcinogenesis
• Chemical carcinogenesis
• Congress
• Contraception -- Complications
• Contraception -- Complications
• Contraceptives, Oral, Combined -- adverse effects
• Contraceptives, Oral, Hormonal -- adverse effects
• Estrogen -- Carcinogenicity
• Estrogen -- Side effects
• Estrogens -- adverse effects
• Estrogens -- therapeutic use
• HEALTH & FITNESS -- Diseases | Cancer
• Hormone Replacement Therapy -- adverse effects
• MEDICAL -- Oncology
• Menopause -- Hormone therapy | Complications
• Menopause -- Hormone therapy | Complications
• Neoplasms -- chemically induced
• Neoplasms -- prevention & control
• Oral contraceptives -- Carcinogenicity
• Oral contraceptives -- Carcinogenicity
• Progestational hormones -- Carcinogenicity
• Progestational hormones -- Side effects
• Progestins -- adverse effects
• Progestins -- therapeutic use
• Women -- Diseases | Risk factors

Genre

• Congress

Language

eng

Summary

Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960s. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combined oral contraceptives were developed that featured lower dose of estrogen and newer, more potent progestogens. The effectiveness and ease of use of combined hormonal contraceptives suggest that they will continue to be used to a significant extent in the future. This ninety-first volume of IARC Monograp

Member of

• IARC monographs on the evaluation of carcinogenic risks to humans, v. 91
• Ebook Central Academic Complete

Cataloging source

QE2

Dewey number

616.994071

Government publication

international or intergovernmental publication

Illustrations

illustrations

Index

index present

LC call number

RC268.7.O72

LC item number

I19 2007eb

Literary form

non fiction

Nature of contents

• dictionaries
• bibliography

NLM call number

• W1
• QZ 202

NLM item number

• IA21I v.91 2007
• I103c 2007

Series statement

IARC monographs on the evaluation of carcinogenic risks to humans

Series volume

v. 91